STOCK TITAN

Park Aerospace Corp. Form 4 Filings

PKE NYSE

Every Form 4 that Park Aerospace Corp. (PKE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow PKE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PKE filings page.

Rhea-AI Summary

PARK AEROSPACE CORP reported that Senior Vice President and Chief Financial Officer Constantine Petropoulos received a grant of stock options covering 25,000 shares of common stock on 2026-08-12. The options have an exercise price of $37.47 per share and expire on 2036-08-12. According to the footnote, this option becomes exercisable as to 25% of the shares on the stated exercise commencement date of 2027-08-12 and as to an additional 25% on each of the next three anniversaries. The filing also lists an existing direct option position with an exercise price of $14.00 per share, expiring on 2035-06-16, relating to 7,500 underlying shares.

Rhea-AI Summary

PARK AEROSPACE CORP President & COO Mark A. Esquivel exercised stock options for 40,000 common shares on 2026-08-13, with strike prices of $12.80, $11.06, and $13.08 per share. The resulting 40,000 shares were sold at a weighted average price of $37.00, with individual trades between $36.80 and $37.625 per share in a same-day-sale exercise. Esquivel continues to hold unexercised options over 25,000 shares at $13.26 and 27,500 shares at $14.00, expiring in 2034 and 2035, respectively.

Rhea-AI Summary

Park Aerospace Corp board chairman and CEO Brian E. Shore reported multiple option exercises and related stock sales. On August 12–13, 2026, he exercised options covering 80,000 shares of common stock at strike prices between $11.06 and $14.00 per share and executed same-day-sale transactions, including sales of 65,000 shares at a weighted average price of $38.17 and 15,000 shares at a weighted average price of $37.75, as described in the footnotes.

Rhea-AI Summary

PARK AEROSPACE CORP’s Board Chairman & CEO, Brian E. Shore, reported a series of option exercises and related stock sales. On August 10–11, 2026, he exercised options for a total of 76,250 shares of Common Stock at exercise prices of $11.58, $12.80 and $14.44 per share and sold 76,250 shares in open-market transactions at weighted-average prices of $37.09 and $37.3163 per share, each noted as part of same-day-sale exercises. The filing also lists remaining “Right to buy option” positions over Common Stock and indirect holdings in several family trusts, for which Shore acts as co-trustee and in some cases disclaims beneficial ownership except to the extent of his pecuniary interest.

Rhea-AI Summary

Park Aerospace president and COO Mark A. Esquivel exercised stock options and sold shares of the company. On July 29, 2026, he exercised options to acquire 60,000 Common Stock shares at exercise prices between $11.58 and $14.44, then sold 60,000 shares at $33.11 per share in substantially concurrent open-market transactions. Remaining equity incentives include right-to-buy options over 20,000 shares at an $11.06 exercise price expiring April 12, 2032 and 27,500 shares at $14.00 expiring June 16, 2035, along with other outstanding grants.

Rhea-AI Summary

Park Aerospace Corp senior vice president Constantine Petropoulos exercised options to acquire 2,500 common shares at $14.00 per share and on the same date sold 2,500 common shares at $36.00 per share. The option originally covered 10,000 shares, with 7,500 option shares remaining and vesting in 25% annual installments beginning June 16, 2026.

Rhea-AI Summary

Park Aerospace director Steven T. Warshaw reported exercising stock options to acquire 3,500 shares of Common Stock at an exercise price of $11.06 per share. Following this transaction, he directly holds 17,250 Common shares. He also continues to hold several “Right to buy option” awards for 3,500 underlying shares each with exercise prices between $11.58 and $14.44 and expirations from 2029 through 2035, which vest in 25% annual installments from their respective commencement dates.

Rhea-AI Summary

Park Aerospace (PKE) reported an insider transaction by its Sr VP and General Manager. On 11/12/2025, the officer exercised an option and acquired 250 shares of common stock at $5.23 (Transaction Code M). Following the transaction, the officer beneficially owns 250 shares directly and 173 shares indirectly through the Employee Stock Purchase Plan.

Outstanding equity awards remain in place, including examples such as options for 750 shares at $14.44 expiring 05/07/2029 and 3,000 shares at $11.58 expiring 04/09/2030. The filing notes options vest 25% at grant and 25% on each of the next three anniversaries.

Rhea-AI Summary

Park Aerospace (PKE) reported insider activity by a director on Form 4. The filing shows an option exercise of 3,000 shares at $5.23 on 11/04/2025, followed by an open‑market sale of 3,000 shares at $19.44 on 11/06/2025. After these transactions, the director held 1,000 common shares directly.

The exercised option was originally granted on 01/12/2017 and expires on 01/12/2026. The filing also lists additional director stock options outstanding with grant dates from 05/07/2020 through 06/16/2026, each covering 3,500 underlying shares with stated exercise prices and expirations.

Rhea-AI Summary

Park Aerospace (PKE) reported an insider equity transaction. A director exercised stock options and acquired 3,000 shares of common stock on 10/24/2025 at an exercise price of $5.23 per share (transaction code M). Following the exercise, the director beneficially owned 13,750 shares directly.

The exercised option dated 01/12/2017 (expiring 01/12/2026) now shows 0 derivative securities remaining. Additional outstanding option grants listed include 3,500 shares per grant with exercise prices of $14.44 (expires 05/07/2029), $11.58 (expires 04/09/2030), $12.8 (expires 04/02/2031), $11.06 (expires 04/12/2032), $13.08 (expires 05/01/2033), $13.26 (expires 06/18/2034), and $14 (expires 06/16/2035). The form notes options vest 25% at grant and an additional 25% on each of the next three anniversaries.